Franklin Resources
IRON icon

Franklin Resources’s Disc Medicine IRON Stock Holding History

Franklin Resources’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-102,016
Closed -$6.35M – 2916
2024
Q1 		$6.35M Sell
102,016
-119,408
-54% -$7.74M ﹤0.01% 1238
2023
Q4 		$12.8M Buy
221,424
+60,403
+38% +$3.09M 0.01% 879
2023
Q3 		$7.56M Buy
161,021
+3,766
+2% +$188K ﹤0.01% 965
2023
Q2 		$6.98M Buy
+157,255
New +$5.58M ﹤0.01% 1017
2022
Q2 		– Sell
-35,726
Closed -$1.49M – 2414
2022
Q1 		$1.49M Sell
35,726
-48,033
-57% -$2.52M ﹤0.01% 1500
2021
Q4 		$7.31M Hold
83,759
– – ﹤0.01% 1135
2021
Q3 		$10.2M Buy
83,759
+30,239
+57% +$4.13M ﹤0.01% 1051
2021
Q2 		$10.4M Buy
53,520
+36,853
+221% +$12.1M ﹤0.01% 1002
2021
Q1 		$6.78M Buy
+16,667
New +$7.43M ﹤0.01% 1057

Other funds holding IRON

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return